J&J to suspend supply of personal care products to Russia By Reuters

(Reuters) – Johnson & Johnson said on Tuesday it would suspend supplies of its personal care products to Russia, adding it would continue to supply medicines and medical devices to the region.

The company, along with several other drugmakers such as Eli Lilly (NYSE:) and Co and Pfizer (NYSE:), said earlier this month that it would halt clinical trial enrollments in Russia.

J&J (NYSE:) had said it was halting registrations in Ukraine and Belarus as well as opening new locations, but pledged to provide essential healthcare products.

Warning: Merged media would like to remind you that the data contained in this site is not necessarily in real time or exact. All prices for CFDs (stocks, indices, futures) and Forex are not provided by exchanges but rather by market makers, and therefore prices may not be accurate and may differ from the actual market price, which which means that the prices are indicative and not suitable for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur due to the use of this data.

Merged media or anyone involved with Fusion Media will accept no liability for any loss or damage resulting from reliance on the information, including data, quotes, charts and buy/sell signals contained in this website . Please be fully informed of the risks and costs associated with trading in the financial markets, it is one of the riskiest forms of investment possible.